The significance of spliceosome mutations in chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 54, Issue 7, 2013, Pages 1364-1366

  Rozovski, Uri ^a   Keating, Michael ^a   Estrov, Zeev ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

CLL; MDS; Secondary AML; Spliceosome mutations

Indexed keywords

MESSENGER RNA PRECURSOR; SMALL NUCLEAR RNA;

ALTERNATIVE RNA SPLICING; CANCER CHEMOTHERAPY; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; EXOME; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HEMATOPOIETIC CELL; HOMEOBOX; HOX GENE; HUMAN; LEUKEMOGENESIS; MESENCHYME CELL; MONOCLONAL B CELL LYMPHOCYTOSIS; MUTATION RATE; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN SUBUNIT; REVIEW; RNA SPLICING; SOMATIC MUTATION; SPLICEOSOME; SURVIVAL RATE; TUMOR CELL;

HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MUTATION; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; RNA SPLICING; SPLICEOSOMES;

EID: 84877926730     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.742528     Document Type: Review

References (21)

1. Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009;136:701-718.
2. Schwerk C, Schulze-Osthoff K. Regulation of apoptosis by alternative pre-mRNA splicing. Mol Cell 2005; 19: 1-13. (Pubitemid 40884653)
3. David CJ, Manley JL. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 2010;24 : 2343-2364.
4. Papaemmanuil E, Cazzola M, Boultwood J, et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011;365:1384-1395.
5. Visconte V, Makishima H, Jankowska A, et al. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 2012; 26: 542-545.
6. Y oshida K, S anada M, S hiraishi Y, et al. F requent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64-69.
7. Makishima H, Visconte V, Sakaguchi H, et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012;119:3203-3210.
8. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011;365 : 2497-2506.
9. Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012; 44: 47-52.
10. Pennisi E. Genomics. ENCODE project writes eulogy for junk DNA. Science 2012;337:1159-1161.
11. Lasho TL, Finke CM, Hanson CA, et al. SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients. Leukemia 2012; 26: 1135-1137.
12. E llis M J, D ing L, S hen D, et al. W hole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012;486 : 353-360.
13. Isono K, Mizutani-Koseki Y, Komori T, et al. Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1. Genes Dev 2005;19:536-541. (Pubitemid 40314986)
14. Krumlauf R. Hox genes in vertebrate development. Cell 1994;78:191-201. (Pubitemid 24241088)
15. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007;26:6766-6776. (Pubitemid 47585101)
16. Harris DM, Hazan-Haley I, Coombes K, et al. Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells. PLoS One 2011;6:e21250.
17. Visconte V, Rogers HJ, Singh J, et al. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood 2012;120:3173-3186.
18. Damm F, Thol F, Kosmider O, et al. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. Leukemia 2012; 26: 1137-1140.
19. Patnaik MM, Lasho TL, Hodnefield JM, et al. SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value. Blood 2012;119 : 569-572.
20. Rossi D, Bruscaggin A, Spina V, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118: 6904-6908.
21. Greco M, Capello D, Bruscaggin A, et al. Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis. Hematol Oncol 2013; 31:54-55.